| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/14/2009 | CN101342284A Chinese medicinal composition for treating hepatitis |
| 01/14/2009 | CN101342282A Chinese medicinal composition for treating gastropathy and preparation method |
| 01/14/2009 | CN101342271A Traditional Chinese medicine for treating qi-blood deficiency caused by tumour chemotherapy and preparation method thereof |
| 01/14/2009 | CN101342261A Preparation method for Chinese medicine for treating hepatitis and cirrhosis |
| 01/14/2009 | CN101342253A Traditional Chinese medicine preparation for treating chronic gastritis |
| 01/14/2009 | CN101342250A Bolus for clearing away heat of the upper part of the body |
| 01/14/2009 | CN101342229A Composition of Canton love-pea vine extract, preparation method and pharmaceutical use |
| 01/14/2009 | CN101342218A Cactus powder processing method |
| 01/14/2009 | CN101342215A Banksia rose capsule, preparation method and quality control method thereof |
| 01/14/2009 | CN101342214A Banksia rose total lactone medicament composition and preparation method thereof |
| 01/14/2009 | CN101342194A Traditional Chinese medicine preparation for treating median or late-stage malignant tumors, chronic hepatitis B, and preparation method thereof |
| 01/14/2009 | CN101342187A Medicament composition for treating dysentery |
| 01/14/2009 | CN101342184A Nutritional composition with health promoting action containing oligosaccharides |
| 01/14/2009 | CN101342167A Medicament composition |
| 01/14/2009 | CN101342166A Application of hydroxyl benzoate and analogue in preparing medicament for preventing and treating hepatitis B virus |
| 01/14/2009 | CN101341979A Health beverage and preparation method |
| 01/14/2009 | CN101341965A Healthy condiment for patients of hepatitis, cirrhosis |
| 01/14/2009 | CN101341920A Mulberry leaf lozenge and preparation method thereof |
| 01/14/2009 | CN101341916A Cold tea for nourishing stomach |
| 01/14/2009 | CN100451018C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/14/2009 | CN100450550C Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 01/14/2009 | CN100450548C Oral patches containing pdacrilin resin composition and its preparing method |
| 01/14/2009 | CN100450534C Medicine for treating hepatic fibrosis and preparation method thereof |
| 01/14/2009 | CN100450522C Medicine for treating chronic gastropathy and its prepn |
| 01/14/2009 | CN100450511C Cooperative medicinal compositions comprising Silybum marianum |
| 01/14/2009 | CN100450509C Medicinal composition for treating hepatitis |
| 01/14/2009 | CN100450508C Medicinal compositions comprising biphenyldicarboxylate |
| 01/14/2009 | CN100450507C Chinese traditional medicine and western medicine composition for treating hepatitis |
| 01/14/2009 | CN100450506C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 01/14/2009 | CN100450502C Active extract of lamtophlomis rotata and its preparing method and use |
| 01/14/2009 | CN100450499C Accessory drug for treating hepatitis |
| 01/14/2009 | CN100450498C Accessory medicinal composition for treating hepatitis |
| 01/14/2009 | CN100450493C Black fungus composite soft capsule and its preparing process |
| 01/14/2009 | CN100450490C Use of caudatin-3-O-beta-D-cymaroside as medicament for treating tumour |
| 01/14/2009 | CN100450485C 5-HT 1a receptor subtype agonists |
| 01/14/2009 | CN100450481C Compound medicine contg. famotidine cyclodextrin clathrate, and its prepn. method |
| 01/14/2009 | CN100450479C Medication in use for bacteriostasis and antiinflammation |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | US7476381 administration of an effective amount of a CC-chemokine mutant having reduced glycosaminoglycan (GAG)-binding activity as compared to the wild type peptide to a subject with hepatitis; counteracts liver fibrotic injury |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 01/09/2009 | CA2623769A1 Composition and method for the prevention of oral disease |
| 01/08/2009 | WO2009006315A1 Modulators of atp-binding cassette transporters for treating cystic fibrosis |
| 01/08/2009 | WO2009006205A1 Compositions and methods for inducing satiety and reducing caloric intake |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005877A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | WO2009005838A2 Process for the preparation of a non-corrosive base solution and methods of using same |
| 01/08/2009 | WO2009005172A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | WO2009005123A1 INTERFERON-β PRODUCTION PROMOTER, AND METHOD FOR PRODUCTION THEREOF |
| 01/08/2009 | WO2009005046A1 Therapeutic agent for ulcerative colitis comprising mizoribine |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009003970A1 Targeting diazo prodrugs for the treatment of gastrointestinal diseases |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/08/2009 | WO2007087026A9 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012097 Polycyclic 1,2,3,4-Tetrahydro-Isoquinoline Derivatives and Compositions Comprising Them As Ppar Modulators |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012064 Compositions controlling pH range of release and/or release rate |
| 01/08/2009 | US20090012063 Novel imidazole derivatives |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012039 Use of methylcobalamin nasal spray to treat disorders |
| 01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011054 Protecting the liver against alcohol and carbon tetrachloride insults by aunique combinations of wasabi root fiber powder, extracts of artichoke leaf, asparagus, kudzu root, oregano, schisandra berry, and notoginseng, sanchi, Gegen root, and spinach dehydrate; synergistic |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011023 Chemotherapeutic compositions |
| 01/08/2009 | US20090010992 Drug formulations for oral transmucosal delivery to pediatric patients |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010902 TLR4 Transcription Activity Suppressor |
| 01/08/2009 | US20090010900 Embryonic Stem Cell Derivatives, and Methods of Making and Using the Same |
| 01/08/2009 | US20090010893 Treating diarrhea in dogs |
| 01/08/2009 | US20090010856 Composition, Comprising Hydrofluoric Acid, for Inhibiting Dental Erosion |
| 01/08/2009 | CA2728985A1 Modulators of atp-binding cassette transporters for treating cystic fibrosis |
| 01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | CA2691716A1 Targeting diazo prodrugs for the treatment of gastrointestinal diseases |
| 01/08/2009 | CA2691107A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011501A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2011494A1 Agent for amelioration of dysphagia, and pharmaceutical or food composition comprising the same |
| 01/07/2009 | EP2011492A1 Gip secretion inhibitor |
| 01/07/2009 | EP2011482A1 Solid preparation for oral application |
| 01/07/2009 | EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
| 01/07/2009 | EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol |
| 01/07/2009 | EP1735304B1 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists |
| 01/07/2009 | EP1663257B1 Use of laxatives for treating irritable bowel syndrome |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |